The article highlights the most relevant trends that can follow COVID's breakneck speed to accelerate the rate of change for pharma and life sciences fields. Hear a key prediction from Rose Higgins, CEO at HealthMyne Inc., which discusses how radiomics will gain ground in drug development and clinical trials.
